|
|
| |
Pipeline
 Commercialization Opportunities
NDI’s model is to identify and select product opportunities in large markets where there is at least one validated product, but where critical clinical needs still exist.
NDI maintains a significant pipeline of commercialization opportunities from three primary sources:
- An extensive network in the medical device and investment community
- Collaborative relations with research and technology transfer organizations and biomedical incubators
- NDI’s own R&D division which designs and develops new products and therapies by leveraging its platform technologies
Formal Collaborations
NDI formally collaborates with leading research and health care institutions including:
- The Ohio Neurostimulation and Neuromodulation Partnership: a collaboration of NDI, Case Western Reserve University, Cleveland Clinic, and MetroHealth Medical Center dedicated to the commercialization of technologies that address critical neurological disorders
- The Cleveland Functional Electronic Stimulation (FES) Center: one of the world’s leading research centers developing advanced neurotech technologies and integrating them into cutting-edge clinical care
NDI also maintains an active facility in North Carolina’s Research Triangle, leveraging strong relationships with Duke University.
|
|
|